Consuming sunflower and fish oils can cause liver inflammation that could lead to cancer, new research suggests.
Scientists discovered having either of the two oils each day triggers damage to the organ and made them susceptible to non-alcoholic steatohepatitis (NASH).
NASH, considered a silent killer and dubbed ‘human foie gras’, can lead to scarring of the liver, which in turn leads to cirrhosis. It can also result in cancer.
Humans often use sunflower oil while cooking, but fish oil is most often obtained through supplements with strong doses.
But olive oil – repeatedly shown to be good for health – caused no such damage, the Spanish researchers concluded from experiments on mice.
Sunflower and fish oils could cause liver inflammation that could lead to cancer (stock)
Their analysis was made by monitoring the DNA of livers of 72 rats fed virgin olive, sunflower or fish oil from birth until they were two.
The University of Granada scientists also conducted tests investigating the ‘internal stress’ levels of animals, their overall health and telomere length.
The findings, published in the Journal of Nutritional Biochemistry, dismiss previous evidence that suggested sunflower oils could actually treat NASH.
Sunflower oil triggered thickening and scarring of liver tissue in rats, while fish oil altered the organ’s telomeres lengths.
Telomeres ‘cap’ the end of DNA strands, with longer lengths being associated with slower ageing, longer lifespans and improved wellbeing.
WHAT IS NON-ALCOHOLIC STEATOHEPATITIS?
Non-alcoholic steatohepatitis (NASH) is a condition where excess fat is stored in the liver, leading to inflammation and cell damage.
This can result in scarring or liver cancer.
NASH affects around three-to-12 per cent of people in the US and between two and three per cent in the UK. It can occur at any age.
It is common in people who are overweight or have type 2 diabetes.
Past studies suggest between 40 and 80 per cent of people with type 2 diabetes have NASH, while 30-to-90 per cent with type 2 diabetes suffer.
High blood pressure also raises the risk.
First-line treatment is often to lose weight via a healthy diet, limiting portion sizes and being more physically active.
Losing at least three-to-five per cent body weight reduces liver fat, while up to 10 per cent eases inflammation.
No medications are approved for treating NASH.
If the condition leads to liver scarring and ultimately organ failure, sufferers may require a transplant.
Source: National Institute of Diabetes and Digestive and Kidney Diseases
They were both shown to make the rats ‘susceptible to NASH’, according to study author Professor José Luis Quiles Morales.
He said: ‘The alterations caused by the long-term consumption of sunflower and fish oils make the liver susceptible to NASH.’
Professor Morales warned that it is a ‘very serious disease that may act as a catalyst for other liver diseases such as cirrhosis and liver cancer’.
NASH is caused by a build-up of fat in the liver and strikes 12 per cent of Americans and six per cent of Europeans, statistics show.
It is estimated cases of the most severe form of non-alcoholic fatty liver disease will soar in years to come due to expanding waistlines.
‘Virgin olive oil is the healthiest option, which has already been proven in relation to diverse aspects of health,’ Professor Morales continued.
Out of the three, virgin olive oil is the only one to preserve liver function throughout rodents’ lives, the research revealed.
It is believed the oils have different effects on the liver because of how fat in them accumulates in rats – which are genetically similar to humans.
This leads to varying levels of inflammation and gene expression – which acts as a switch to control the amount of proteins made in the body.
Professor Morales added the study shows that the over-consumption of dietary fats, other than virgin olive oil, is ‘dangerous’.
Sunflower oil and virgin olive oil – a key ingredient of the Mediterranean diet – have both become widely available in recent years for their health claims.
But sales of fish oil have lagged behind. It is available as a liquid in some health food stores, but is most often obtained through tablet supplements.
But Case Western Reserve University scientists discovered that sunflower oils could alleviate symptoms of NASH in mice back in 2013.
The oil, high in vitamin E, allowed the rodents to avoid symptoms. Humans suffering from NASH can experience weight loss, fatigue and dull aches in their stomachs.
It comes after the MailOnline reported in June that drug giants are trying to jump on the global rise of NASH – because it could make them billions.
WHY IS NASH THE CENTRE OF ATTENTION FOR DRUG FIRMS?
Drug giants are trying to jump on the global rise of a silent killer dubbed ‘human foie gras’ that could make them billions.
The disease, formally known as non-alcoholic steatohepatitis (NASH), is caused by a build-up of fat in the liver due to expanding waistlines.
Pharmaceutical companies began ramping up their response to the preventable condition that is driven by bulging stomachs two years ago.
But figures last June suggested NASH is a potential goldmine that could be worth more than £17 billion ($22 billion) by 2026 if the obesity crisis continues.
Currently no approved treatments exist to stop those with fatty diets from falling victim, but a huge new market is tempting drug firms in.
With intense competition and pricing pressure eroding sales of medicines for many conditions, drug firms see NASH as an enormous new market.
Experts believe the market will grow by 45 per cent each year – mainly in the US, Europe and Japan – with the eventual rollout of drugs.